Annual Revenue
$54.32 B
-$3.74 B-6.44%
31 December 2023
Summary
AbbVie annual revenue is currently $54.32 billion, with the most recent change of -$3.74 billion (-6.44%) on 31 December 2023. During the last 3 years, it has risen by +$8.51 billion (+18.59%). ABBV annual revenue is now -6.44% below its all-time high of $58.05 billion, reached on 31 December 2022.ABBV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$14.46 B
-$2.00 M-0.01%
30 September 2024
Summary
AbbVie quarterly revenue is currently $14.46 billion, with the most recent change of -$2.00 million (-0.01%) on 30 September 2024. Over the past year, it has increased by +$533.00 million (+3.83%). ABBV quarterly revenue is now -4.37% below its all-time high of $15.12 billion, reached on 31 December 2022.ABBV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$55.53 B
+$533.00 M+0.97%
30 September 2024
Summary
AbbVie TTM revenue is currently $55.53 billion, with the most recent change of +$533.00 million (+0.97%) on 30 September 2024. Over the past year, it has increased by +$395.00 million (+0.72%). ABBV TTM revenue is now -4.34% below its all-time high of $58.05 billion, reached on 31 December 2022.ABBV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.4% | +3.8% | +0.7% |
| 3 y3 years | +18.6% | +0.8% | +0.7% |
| 5 y5 years | +65.8% | +70.5% | +69.0% |
ABBV Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.4% | +18.6% | -4.4% | +18.3% | -4.3% | +2.2% |
| 5 y | 5 years | -6.4% | +65.8% | -4.4% | +70.5% | -4.3% | +69.0% |
| alltime | all time | -6.4% | +282.1% | -4.4% | +271.1% | -4.3% | +1325.1% |
AbbVie Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.46 B(-0.0%) | $55.53 B(+1.0%) |
| June 2024 | - | $14.46 B(+17.5%) | $55.00 B(+1.1%) |
| Mar 2024 | - | $12.31 B(-13.9%) | $54.40 B(+0.2%) |
| Dec 2023 | $54.32 B(-6.4%) | $14.30 B(+2.7%) | $54.32 B(-1.5%) |
| Sept 2023 | - | $13.93 B(+0.4%) | $55.14 B(-1.6%) |
| June 2023 | - | $13.87 B(+13.4%) | $56.02 B(-1.3%) |
| Mar 2023 | - | $12.22 B(-19.2%) | $56.74 B(-2.3%) |
| Dec 2022 | $58.05 B(+3.3%) | $15.12 B(+2.1%) | $58.05 B(+0.4%) |
| Sept 2022 | - | $14.81 B(+1.6%) | $57.82 B(+0.8%) |
| June 2022 | - | $14.58 B(+7.7%) | $57.35 B(+1.1%) |
| Mar 2022 | - | $13.54 B(-9.1%) | $56.73 B(+0.9%) |
| Dec 2021 | $56.20 B(+22.7%) | $14.89 B(+3.8%) | $56.20 B(+1.9%) |
| Sept 2021 | - | $14.34 B(+2.7%) | $55.17 B(+2.7%) |
| June 2021 | - | $13.96 B(+7.3%) | $53.73 B(+7.0%) |
| Mar 2021 | - | $13.01 B(-6.1%) | $50.20 B(+9.6%) |
| Dec 2020 | $45.80 B(+37.7%) | $13.86 B(+7.4%) | $45.80 B(+12.7%) |
| Sept 2020 | - | $12.90 B(+23.8%) | $40.65 B(+12.2%) |
| June 2020 | - | $10.43 B(+21.0%) | $36.23 B(+6.4%) |
| Mar 2020 | - | $8.62 B(-1.0%) | $34.06 B(+2.4%) |
| Dec 2019 | $33.27 B(+1.6%) | $8.70 B(+2.7%) | $33.27 B(+1.2%) |
| Sept 2019 | - | $8.48 B(+2.7%) | $32.87 B(+0.7%) |
| June 2019 | - | $8.26 B(+5.5%) | $32.62 B(-0.1%) |
| Mar 2019 | - | $7.83 B(-5.7%) | $32.65 B(-0.3%) |
| Dec 2018 | $32.75 B(+16.1%) | $8.30 B(+0.8%) | $32.75 B(+1.8%) |
| Sept 2018 | - | $8.24 B(-0.5%) | $32.19 B(+4.0%) |
| June 2018 | - | $8.28 B(+4.3%) | $30.95 B(+4.5%) |
| Mar 2018 | - | $7.93 B(+2.5%) | $29.61 B(+4.9%) |
| Dec 2017 | $28.22 B | $7.74 B(+10.6%) | $28.22 B(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $7.00 B(+0.7%) | $27.27 B(+2.1%) |
| June 2017 | - | $6.94 B(+6.2%) | $26.71 B(+1.9%) |
| Mar 2017 | - | $6.54 B(-3.8%) | $26.22 B(+2.3%) |
| Dec 2016 | $25.64 B(+12.2%) | $6.80 B(+5.7%) | $25.64 B(+1.6%) |
| Sept 2016 | - | $6.43 B(-0.3%) | $25.24 B(+2.0%) |
| June 2016 | - | $6.45 B(+8.3%) | $24.75 B(+4.1%) |
| Mar 2016 | - | $5.96 B(-6.9%) | $23.78 B(+4.0%) |
| Dec 2015 | $22.86 B(+14.5%) | $6.40 B(+7.7%) | $22.86 B(+4.3%) |
| Sept 2015 | - | $5.94 B(+8.6%) | $21.91 B(+4.4%) |
| June 2015 | - | $5.47 B(+8.6%) | $20.99 B(+2.7%) |
| Mar 2015 | - | $5.04 B(-7.6%) | $20.44 B(+2.4%) |
| Dec 2014 | $19.96 B(+6.2%) | $5.45 B(+8.6%) | $19.96 B(+1.7%) |
| Sept 2014 | - | $5.02 B(+1.9%) | $19.62 B(+1.9%) |
| June 2014 | - | $4.93 B(+8.0%) | $19.26 B(+1.2%) |
| Mar 2014 | - | $4.56 B(-10.7%) | $19.02 B(+1.2%) |
| Dec 2013 | $18.79 B(+2.2%) | $5.11 B(+9.7%) | $18.79 B(-0.5%) |
| Sept 2013 | - | $4.66 B(-0.7%) | $18.89 B(+0.8%) |
| June 2013 | - | $4.69 B(+8.4%) | $18.73 B(+1.1%) |
| Mar 2013 | - | $4.33 B(-16.8%) | $18.54 B(+0.8%) |
| Dec 2012 | $18.38 B(+5.4%) | $5.21 B(+15.5%) | $18.38 B(+1.9%) |
| Sept 2012 | - | $4.51 B(+0.3%) | $18.04 B(+0.6%) |
| June 2012 | - | $4.49 B(+7.7%) | $17.94 B(+1.2%) |
| Mar 2012 | - | $4.17 B(-14.2%) | $17.72 B(+1.6%) |
| Dec 2011 | $17.44 B(+11.5%) | $4.86 B(+10.3%) | $17.44 B(+38.7%) |
| Sept 2011 | - | $4.41 B(+3.1%) | $12.58 B(+54.0%) |
| June 2011 | - | $4.27 B(+9.7%) | $8.17 B(+109.7%) |
| Mar 2011 | - | $3.90 B | $3.90 B |
| Dec 2010 | $15.64 B(+10.0%) | - | - |
| Dec 2009 | $14.21 B | - | - |
FAQ
- What is AbbVie annual revenue?
- What is the all time high annual revenue for AbbVie?
- What is AbbVie annual revenue year-on-year change?
- What is AbbVie quarterly revenue?
- What is the all time high quarterly revenue for AbbVie?
- What is AbbVie quarterly revenue year-on-year change?
- What is AbbVie TTM revenue?
- What is the all time high TTM revenue for AbbVie?
- What is AbbVie TTM revenue year-on-year change?
What is AbbVie annual revenue?
The current annual revenue of ABBV is $54.32 B
What is the all time high annual revenue for AbbVie?
AbbVie all-time high annual revenue is $58.05 B
What is AbbVie annual revenue year-on-year change?
Over the past year, ABBV annual revenue has changed by -$3.74 B (-6.44%)
What is AbbVie quarterly revenue?
The current quarterly revenue of ABBV is $14.46 B
What is the all time high quarterly revenue for AbbVie?
AbbVie all-time high quarterly revenue is $15.12 B
What is AbbVie quarterly revenue year-on-year change?
Over the past year, ABBV quarterly revenue has changed by +$533.00 M (+3.83%)
What is AbbVie TTM revenue?
The current TTM revenue of ABBV is $55.53 B
What is the all time high TTM revenue for AbbVie?
AbbVie all-time high TTM revenue is $58.05 B
What is AbbVie TTM revenue year-on-year change?
Over the past year, ABBV TTM revenue has changed by +$395.00 M (+0.72%)